Skip to content

Safety evaluation of perioperative SARS-CoV-2 infection of liver transplantation patients: A retrospective study of one single-center experience in China

Safety evaluation of perioperative SARS-CoV-2 infection of liver transplantation patients: A retrospective study of one single-center experience in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070656
Enrollment
Unknown
Registered
2023-04-19
Start date
2023-04-30
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer and cirrhosis

Interventions

Group treated with anti-COVID-19 drugs:None
Group without anti-COVID-19 drugs:None

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) perioperative laboratory examination showed COVID-19 infection; (2) the whole body was in good condition and there were no serious organic lesions of heart, lung, kidney and other important organs. The anesthesiologist was considered to be able to tolerate the operation after preoperative anesthesia evaluation; (3) the age was more than 18 years old; (4) the first operation was performed in our hospital, and all of them were orthotopic liver transplantation.

Exclusion criteria

Exclusion criteria: (1) no COVID-19 infection, (2) lack of clinical and pathological data, (3) no follow-up data or loss of follow-up.

Design outcomes

Primary

MeasureTime frame
Transaminase;Bilirubin;

Secondary

MeasureTime frame
Complication;Postoperative immunosuppressive regimen;Anti novel coronavirus treatment strategies;

Countries

China

Contacts

Public ContactXinjun Lu

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Xinjun.Lu@foxmail.com+86 18666005715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026